Home | Welcome to Contract Pharma   
Last Updated Tuesday, June 2 2015

Print

Search Results for 'Biomanufacturing'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Contract Service Directory Companies

View All Companies »


Search Results:

By Eric S. Langer, BioPlan Associates
Published June 2, 2015
Downstream purification creating chronic problems Read More »
Published May 14, 2015
Catalent to provide biomanufacturing activities for MANF protein Read More »
CMOs Demanding Easier-to-Integrate Single-use Devices
By Jean-Claude Lupis and Eric S. Langer, BioPlan Associates
Published May 6, 2015
Disposables’ implementation and integration critical; suppliers being put on notice Read More »
Published April 24, 2015
Multi-purpose facility is among the largest bulk API manufacturing facilities for recombinant microbial biologics Read More »
Published March 25, 2015
Will receive as much as £652,000 to expand bioproduction research Read More »
Newsmakers: Margaret Timony
Published March 6, 2015
What’s Happening at DCAT Week ’15? Read More »
Outsourcing Budgets Continue to Shine
By Eric S. Langer, BioPlan Associates
Published March 6, 2015
Preliminary study data indicates continued spending on outsourcing Read More »
Changing Prices in the Bio CMO Market
By William Downey , President, HighTech Business Decisions
Published March 6, 2015
A dynamic market for biopharmaceutical contract manufacturing services is seeing prices rise and fall Read More »
Overcoming Stem Cell Manufacturing Obstacles
By Kristin Brooks
Published February 26, 2015
Scale-up and manufacture achieved through Cymerus process Read More »
Published February 19, 2015
Will manufacture GMP Cymerus MSC product for clinical and collaboration programs Read More »
Published February 17, 2015
To provide custom biomanufacturing for commercial production Read More »
By Eric S. Langer and Jean-Claude Lupis, BioPlan Associates
Published January 29, 2015
Keep your eye on these trends in 2015. Read More »
Published December 2, 2014
Catalent to provide cell line engineering, process development, and manufacturing Read More »
Published November 20, 2014
Incorporates multiple technologies aimed at greater speed and efficiency Read More »
Newsmakers: CMOs and CDMOs Have a Trade Association to Call Their Own
Published November 13, 2014
The new Pharma & Biopharma Outsourcing Association aims to help advance the industry’s regulatory, legislative and business interests. Read More »
Biopharm Executives Point to Better CMO Performance
By Eric S. Langer, BioPlan Associates, Inc.
Published October 14, 2014
Better process control and increased adoption of single-use systems played a part in improving downstream manufacturing Read More »
Published September 24, 2014
PBOA to represent CMO/CDMO interests Read More »
Published August 27, 2014
Training center to aid biopharma companies with manufacturing challenges Read More »
4	Merck & Co.
Published July 21, 2014
Headquarters: Whitehouse Station, NJ twitter.com/Merck www.merck.com   Headcount:  76,000   Year Established:  2009    Pharma Reveneus: $… Read More »
Published June 3, 2014
Gains Alternating Tangential Flow (ATF) System Read More »
Published April 3, 2014
Kemwell expands lyophilization capacity Read More »
Published April 3, 2014
Catalent, CiRA in regenerative therapy pact Read More »
Published April 3, 2014
Catalent Pharma Solutions has increased its minority investment in Redwood Bioscience. The decision was based on data generated by the SMARTag ADC platform, a precision protein-chemical engineering platform and novel toxin-linker technology developed… Read More »
By Kristin Brooks
Published March 24, 2014
SMARTag ADC Technology achieves key milestone Read More »
By Kristin Brooks
Published March 14, 2014
Will leverage SmartFactory single-use automation platform Read More »
Too Much CMO Capacity?
By Eric A. Langer, BioPlan Associates
Published March 7, 2014
A decade ago, there were dire concerns that the biopharmaceutical industry was headed for a severe crisis. There was, it was thought, inadequate mammalian manufacturing capacity to support the development pipeline. In particular, fears grew about sho… Read More »
By Kristin Brooks
Published February 26, 2014
To manufacture Symphogen’s antibody mixture product candidates Read More »
By Kristin Brooks
Published January 23, 2014
Schuster brings 25 years of global experience Read More »
By Kristin Brooks
Published December 13, 2013
Rezac brings international experience Read More »
CMOs Demanding More Innovations
By Eric Langer , BioPlan Associates
Published November 13, 2013
Chromatography and single-use equipment top list Read More »
By Gil Roth
Published October 30, 2013
Signs pact with Opthea Read More »
Published October 23, 2013
Bouman to head DSM Biologics/BioSolutions Read More »
Bio-CMO Capacity Constraints
By Eric Langer, BioPlan Associates
Published September 5, 2013
What they’re doing about them Read More »
Transforming Bigfoot Into Speed Racer
By Jeff Odum, IPS
Published September 5, 2013
The facility of the future movement in biologics manufacturing Read More »
Published August 1, 2013
To provide process and method development, scale-up, clinical supply for rare disease therapy Read More »
Published June 17, 2013
To manufacture materials for anti-nerve gas agent Read More »
Published April 26, 2013
Quadruples bio-manufacturing capacity with single-use tech Read More »
Published April 10, 2013
DeSeabra brings 20 years of leadership experience Read More »
Global Changes in Biomanufacturing
By Eric Langer, BioPlan Associates, Inc.
Published April 3, 2013
A retrospective analysis of CMO Trends Read More »
Bio-CMO Industry Trends
By William Downey and Jennifer Hartigan, HighTech Business Decisions
Published April 3, 2013
The market continues its upswing Read More »
Fill-Finish Innovation
By Ronald A. Rader and Eric S. Langer, BioPlan Associates, Inc.
Published March 13, 2013
Showing Sparks of Life Read More »
Published February 26, 2013
Aims to commercialize six products in emerging markets Read More »
Published January 15, 2013
Technology is applicable to multiple biological products Read More »
Clinical Testing Technology
By Kevin Maskell, Merck Millipore
Published November 9, 2012
Applying flow cytometry to clinical trial samples Read More »
Biosimilars: The Race to Market Continues…
By Fiona Greer, SGS Life Science Services
Published October 9, 2012
Going for the Gold Read More »
Future Bio-Capacity Constraints
By Eric S. Langer, BioPlan Associates, Inc.
Published September 6, 2012
Top 10 factors from a new survey Read More »
Continuous Flow Manufacturing
By Aloke Das, Beroe Inc.
Published September 6, 2012
Implications on downstream biologics processing Read More »
By Gil Roth
Published August 28, 2012
Biomanufacturing deal covers global Phase II-III trials Read More »
By Gil Roth
Published June 19, 2012
Will boost cGMP mammalian cell culture at Billingham Read More »
By Gil Roth
Published June 18, 2012
Major pharma signs commercialization deal Read More »


Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On